Business
Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2026 / Emerging Growth Research today announced the release of its Q1:26 Quarterly Update Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), upgrading the Company to a Buy rating and increasing its ...
About this update from Sbc Medical Group Holdings Incorporated
[{"type":"text","content":"NEW YORK CITY, NY / ACCESS Newswire / May 20, 2026 / Emerging Growth Research today announced the release of its Q1:26 Quarterly Update Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), upgrading the Company to a Buy rating and increasing its 12-month price target to $10.00 from $9.00, representing significant potential upside from the Company's recent share price of $2.89 as of May 19, 2026.","length":406,"tagName":"p"},{"type":"text","content":"The Quarterly Update highlights SBC's expectation for a return to revenue growth in 2026 following the completion of pricing-related headwinds experienced during 2025, while emphasizing the Company's strong cash position, expanding clinic footprint, and long-term global growth strategy.","length":295,"tagName":"p"},{"type":"text","content":"Key Highlights from the Q1:26 Quarterly Update:","length":47,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Return to Growth Expected in 2026: Emerging Growth Research believes the impact of SBC's early-2025 franchise fee restructuring is now largely absorbed, positioning the Company for renewed revenue growth beginning in 2026.","length":226,"tagName":"p"}]},{"val":[{"type":"text","content":"Underlying Business Trends Remain Strong: Q1:26 same-clinic sales increased +6% year-over-year, while customer growth rose +10% year-over-year to approximately 6.7 million annual visits with a 72% repeat rate.","length":209,"tagName":"p"}]},{"val":[{"type":"text","content":"Sequential Improvement in Financial Results: While Q1:26 revenue declined 9% year-over-year to $43.1 million, revenue increased +9% sequentially from Q4:25. Operating profit also increased +38% sequentially.","length":207,"tagName":"p"}]},{"val":[{"type":"text","content":"Significant Cash Position Supports Expansion: SBC ended Q1:26 with approximately $167 million in cash and only modest debt levels, leaving the Company with a strong net cash position relative to its market capitalization.","length":221,"tagName":"p"}]},{"val":[{"type":"text","content":"Continued Clinic Expansion: SBC expanded its clinic network to 284 locations, up +13% year-over-year, as management continues to pursue its long-term objective of reaching 1,000 clinics globally over the next nine years.","length":220,"tagName":"p"}]},{"val":[{"type":"text","content":"Internatio...